Home/Filings/4/0000950170-25-099207
4//SEC Filing

Assis Alessandra Faccin 4

Accession 0000950170-25-099207

CIK 0001674862other

Filed

Jul 27, 8:00 PM ET

Accepted

Jul 28, 4:30 PM ET

Size

9.0 KB

Accession

0000950170-25-099207

Insider Transaction Report

Form 4
Period: 2025-07-25
Assis Alessandra Faccin
SVP and GM, Life Sciences
Transactions
  • Tax Payment

    Common Stock

    2025-07-25$51.26/sh1,327$68,0224,946 total
  • Exercise/Conversion

    Common Stock

    2025-07-25$51.26/sh+3,123$160,0856,273 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-07-253,12312,498 total
    Common Stock (3,123 underlying)
Footnotes (4)
  • [F1]Balance includes additional restricted stock units acquired in lieu of cash dividends.
  • [F2]Payment of tax liability by withholding securities incident to the vesting of Restricted Stock Units acquired pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3.
  • [F3]Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock.
  • [F4]On July 25, 2024, the Reporting Person was granted 15,234 restricted stock units, vesting over a three-year period, with 20% vesting on July 25, 2025, 20% vesting on July 25, 2026, and 60% vesting on July 25, 2027, provided that the Reporting Person remains in continuous employment with the Issuer.

Documents

1 file

Issuer

ASHLAND INC.

CIK 0001674862

Entity typeother

Related Parties

1
  • filerCIK 0001931500

Filing Metadata

Form type
4
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 4:30 PM ET
Size
9.0 KB